Nrf2 activator-25
Nrf2 activator-25 is a Nrf2 activator. Nrf2 activator-25 promotes the dissociation of Nrf2 from Keap1 (with a Kd of 21.3 μM for Keap1), drives Nrf2 nuclear translocation, and increases the production of downstream antioxidant enzymes. Nrf2 activator-25 inhibits apoptosis, ferroptosis and vascular fibrosis, and protects vascular endothelial cells from damage. Nrf2 activator-25 can be used in the research of diabetic vascular diseases.
For research use only. We do not sell to patients.
- Formula: C15H17NO3
- Molecular Weight:259.30
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Nrf2 activator-25 (Compound 3h) at 20 μM maintains the survival rate of serum- and growth factor-starved human umbilical vein endothelial cells (HUVECs) at 93.61%, with extremely low cytotoxicity[1].
Nrf2 activator-25 (5-20 μM; 6-24 h) concentration-dependently inhibits apoptosis and ferroptosis of HUVECs damaged by ox-LDL, high glucose and CoCl2 after 12 h of treatment[1].
Nrf2 activator-25 (5-20 μM; 6-12 h) concentration-dependently inhibits the expression of ICAM-1 and VCAM-1 in HUVECs damaged by ox-LDL, high glucose and CoCl2[1].
Nrf2 activator-25 (20 μM; 6-24 h) protects HUVECs injured by ox-LDL, high glucose and CoCl2 against mitochondrial membrane potential loss[1].
Nrf2 activator-25 (20 μM; 6-24 h) inhibits ROS accumulation in HUVECs damaged by ox-LDL, high glucose and CoCl2[1].
Nrf2 activator-25 (5-20 μM; 6-24 h) concentration-dependently inhibits lipid peroxidation in HUVECs damaged by ox-LDL, high glucose, and CoCl2, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:ox-LDL-injured human umbilical vein endothelial cells (HUVECs)
-
Concentration:5, 10 and 20 μM
-
Incubation Time:6 h
-
Result:Reduced the percentage of apoptotic HUVECs with condensed/fragmented nuclei in a concentration-dependent manner, relative to ox-LDL-only treated cells.
-
Cell Line:high glucose (HG)-injured human umbilical vein endothelial cells (HUVECs)
-
Concentration:5, 10 and 20 μM
-
Incubation Time:24 h
-
Result:Reduced the percentage of apoptotic HUVECs with condensed/fragmented nuclei in a concentration-dependent manner, relative to HG-only treated cells.
-
Cell Line:CoCl2-injured human umbilical vein endothelial cells (HUVECs)
-
Concentration:5, 10 and 20 μM
-
Incubation Time:12 h
-
Result:Reduced the percentage of apoptotic HUVECs with condensed/fragmented nuclei in a concentration-dependent manner, relative to CoCl2-only treated cells.
-
Cell Line:ox-LDL-injured human umbilical vein endothelial cells (HUVECs)
-
Concentration:5, 10 and 20 μM
-
Incubation Time:6 h
-
Result:Concentration-dependently reduced the ox-LDL-induced upregulation of ICAM-1 and VCAM-1 protein levels, with greater efficacy than tBHQ.
-
Cell Line:high glucose (HG)-injured human umbilical vein endothelial cells (HUVECs)
-
Concentration:5, 10 and 20 μM
-
Incubation Time:24 h
-
Result:Concentration-dependently reduced the HG-induced upregulation of ICAM-1 and VCAM-1 protein levels, with greater efficacy than tBHQ.
-
Cell Line:CoCl2-injured human umbilical vein endothelial cells (HUVECs)
-
Concentration:5, 10 and 20 μM
-
Incubation Time:12 h
-
Result:Concentration-dependently reduced the CoCl2-induced upregulation of ICAM-1 and VCAM-1 protein levels, with greater efficacy than tBHQ.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male, 6-8 weeks old, STZ-induced diabetes)[1]
-
Dosage:1 mg/kg
-
Administration:i.p.; daily; 8 weeks
-
Result:Significantly alleviated intimal damage and vascular fibrosis, with lower relative fibrosis severity compared to the STZ-only group.
Reduced the proportion of apoptotic cells in the thoracic aortic endothelium compared to the STZ-only group.
Decreased aortic tissue MDA and LPO content relative to the STZ-only group.
Increased aortic tissue GSH content relative to the STZ-only group.
Chemical Information
-
Molecular Weight 259.30
-
Formula C15H17NO3
-
SMILES
O=C(N1C=CC=C1)OC2=CC=C(O)C(C(C)(C)C)=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)